You searched for "GIRFT"

1987 results found

Wet AMD outcomes post cataract surgery

The authors present the findings of a retrospective study looking at the progression of wet age-related macular degeneration (AMD) in patients who underwent cataract surgery. They recruited a series of 111 patients of which 38 were men and 73 were...

At what age do children start to negatively judge ptosis?

The authors present a cohort study to assess for the presence of peer bias against ptosis. Recruitment took place in nursery and primary schools, of children aged three to six-years-old. An exclusion criterion was the presence of a visible ophthalmic...

Use of botulinum toxin A in the treatment of intermittent exotropia

In this prospective cohort study, the authors aimed to evaluate the efficiency of botulinum toxin A (BTA) injection in the treatment of intermittent exotropia (IXT) and examine factors affecting treatment outcomes. Seventy-four patients diagnosed with any type of IXT were...

Significant associations to presence of significant retinal haemorrhages in suspected child abuse

The authors aimed to extract statistically significant associations between non-ocular clinical and diagnostic imaging findings and the presence of significant retinal haemorrhages, and then develop an evidence-based screening algorithm to determine when to consult an ophthalmologist in suspected child abuse...

A review of the risk of nonarteritic anterior ischaemic optic neuropathy post-cataract surgery

A systematic review and meta-analysis are presented with the aim of assessing whether cataract surgery increases the risk of non-arteritic anterior ischaemic optic neuropathy (NAION) and identify potential predictors of risk. The search strategy components are outlined in detail. A...

Ten-year experience with intracameral chemotherapy for aqueous seeding in retinoblastoma: long-term efficacy, safety and toxicity

This is a retrospective review of all consecutive patients with primary (n=4) or secondary non-iatrogenic (n=16) aqueous seeding (AS) treated by intracameral chemotherapy (ICC) in Lausanne between 2011 and 2020 with a minimum follow-up of one year. Aqueous seeding control...

Features and associations of CVI in Australian children

The authors report the findings of an audit of data from the Australian Childhood Vision Impairment Register (ACVIR) of 132 Australian children with a primary diagnosis of cerebral visual impairment (CVI). All children were living in Australia, 49% female, 51%...

Clinical features of basic acquired nonaccommodative esotropia requiring surgery

Basic acquired nonaccommodative esotropia (BANAET) is a concomitant esotropia occurring after the age of six months without significant refractive error or accommodative element. Esotropia is similar for both near and distance and children have prior binocular single vision. The purpose...

Hanson Medical is bringing Market Leading Norlase® Eye Lasers to the UK

Hanson Medical, a leading supplier of medical technology, has secured an exclusive agreement to become the sole distributor of Norlase's next-generation ophthalmic laser solutions. Hanson Medical will be offering all three of Norlase’s lasers to UK and Republic of Ireland...

Doctor by the sea (Pete’s Hidden Curriculum Part 1)

See Pete's Hidden Curriculum Part 2 here. “They can always hurt you more.” This is The Fat Man’s Law Number 8 from the book The House of God by Samuel Shem. For those that have not read this book, it...

Surgitrac confirms 2026 events so far

Surgitrac Instruments is delighted to announce the first confirmed meetings for our 2026 events calendar, where our team will once again be out on the road meeting ophthalmic professionals across the UK. Our Clinical Specialists will be representing Surgitrac at...

Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow up

Chavanod (near Annecy), France, March 29, 2023 - Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, announced the positive results of a 24-month post-operative follow-up on a clinical trial of CID, its first generation Cilio-scleral Inter-positioning Device.